BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2252033)

  • 1. Reversal of chronic hepatic encephalopathy by colonic exclusion: poor correlation with blood GABA levels.
    Thirlby RC; Fenster LF; Coatsworth JJ; Petty F
    Am J Gastroenterol; 1990 Dec; 85(12):1637-41. PubMed ID: 2252033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum gamma-aminobutyric acid (GABA) levels in patients with hepatic encephalopathy.
    Minuk GY; Winder A; Burgess ED; Sarjeant EJ
    Hepatogastroenterology; 1985 Aug; 32(4):171-4. PubMed ID: 4054811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association of plasma ammonia and GABA levels and the degree of hepatic encephalopathy].
    Campollo O; MacGillivray BB; McIntyre N
    Rev Invest Clin; 1992; 44(4):483-90. PubMed ID: 1485027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The blood level of gamma-aminobutyric acid in patients with liver cirrhosis and portacaval anastomosis].
    Kretz FJ; Löscher W; Dillinger U
    Anaesthesiol Reanim; 1991; 16(3):169-74. PubMed ID: 1888423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma gamma aminobutyric acid concentrations provide evidence of different mechanisms in the pathogenesis of hepatic encephalopathy in acute and chronic liver disease.
    Levy LJ; Losowsky MS
    Hepatogastroenterology; 1989 Dec; 36(6):494-8. PubMed ID: 2613171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked increases of plasma gamma-aminobutyric acid concentrations in cirrhotic patients with portacaval shunts are not associated with alterations of cerebral functions.
    Löscher W; Kretz FJ; Karavias T; Dillinger U
    Digestion; 1991; 49(4):212-20. PubMed ID: 1797600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic hepatic encephalopathy following portacaval shunt: management by loop ileostomy.
    Hebbard GS; Jenney AW; Gibson PR; Jacobs R; Penfold JC
    Aust N Z J Surg; 1993 Mar; 63(3):231-4. PubMed ID: 8311803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatic coma in patients with chronic diseases of the liver and its treatment].
    Bendar ZA; Izianova VL
    Ter Arkh; 1973; 45(2):16-23. PubMed ID: 4588520
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduction of highly elevated plasma levels of gamma-aminobutyric acid does not reverse hepatic coma.
    Löscher W; Kretz FJ; Tung LC; Dillinger U
    Hepatogastroenterology; 1989 Dec; 36(6):504-5. PubMed ID: 2613172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic refractory encephalopathy. Evaluation of an ileostomy 22 years after portacaval shunt.
    Willson RA
    Dig Dis Sci; 1981 Sep; 26(9):839-42. PubMed ID: 7285749
    [No Abstract]   [Full Text] [Related]  

  • 11. Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis.
    Huber M; Rössle M; Siegerstetter V; Ochs A; Haag K; Kist M; Blum HE
    Hepatogastroenterology; 2001; 48(38):541-4. PubMed ID: 11379349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatic encephalopathy after portacaval anastomosis. Retrospective analysis of its occurrence at the clinical and subclinical level].
    Troiani R; Lombardi M; Dell'Amico P; Isoppi E; Vinciguerra G; Pincione F; Ambrogi M; Nicosia F; Sicari A
    Minerva Dietol Gastroenterol; 1985; 31(2):167-74. PubMed ID: 4034023
    [No Abstract]   [Full Text] [Related]  

  • 13. Cerebrospinal fluid content of diazepam binding inhibitor in chronic hepatic encephalopathy.
    Rothstein JD; McKhann G; Guarneri P; Barbaccia ML; Guidotti A; Costa E
    Ann Neurol; 1989 Jul; 26(1):57-62. PubMed ID: 2549847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Double blind study of lactulose in 8 patients with chronic hepatic encephalopathy after portocaval shunt].
    Germain L; Frexinos J; Louis A; Ribet A
    Arch Fr Mal App Dig; 1973 Jun; 62(4):293-302. PubMed ID: 4594756
    [No Abstract]   [Full Text] [Related]  

  • 15. [Double blind study of lactulose in 8 patients with chronic hepatic encephalopathy after portocaval shunt].
    Germain L; Frexinos J; Louis A; Ribet A
    Arch Fr Mal App Dig; 1973 Jun; 62(4):293-302. PubMed ID: 4594755
    [No Abstract]   [Full Text] [Related]  

  • 16. Experimental, clinical, and metabolic results of side-to-side portacaval shunt for intractable cirrhotic ascites.
    Orloff MJ; Orloff MS; Orloff SL; Girard B
    J Am Coll Surg; 1997 Jun; 184(6):557-70. PubMed ID: 9179111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic encephalopathy evaluation.
    Delgado RL
    Lab Res Methods Biol Med; 1983; 7():587-601. PubMed ID: 6353114
    [No Abstract]   [Full Text] [Related]  

  • 18. [Postoperative syndromes after portacaval shunt in patients with cirrhosis of the liver (author's transl)].
    Karavias T; Häring R; Weber D
    Leber Magen Darm; 1982 Apr; 12(2):85-9. PubMed ID: 7098748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between tumor necrosis factor-alpha and ammonia in patients with hepatic encephalopathy due to chronic liver failure.
    Odeh M; Sabo E; Srugo I; Oliven A
    Ann Med; 2005; 37(8):603-12. PubMed ID: 16338762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Complex therapy of chronic hepatic encephalopathy supplemented with probiotic: comparison of two studies].
    Boca M; Vyskocil M; Mikulecký M; Ebringer L; Kolibás E; Kratochvíl'ová H; Buzgová D
    Cas Lek Cesk; 2004; 143(5):324-8. PubMed ID: 15305769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.